Pharmalicensing.com
Latest: Watch here for details of new products and services.
RSS Feeds
Advanced search

Login  Register

Our Products
Overview
Partnering Search
Company Profiling
Partneringtools
Reports
Partnering Consulting
Comparison
 
Forums
Visit our forums
 
Jobs
Visit our job site
 
Case Studies
See what others think about our service
 
Newsletter
Partnering update
Key reports
Subscribe
 
Quick Links
Profile now
Register now
Profiled companies
Featured events
Industry news
PR Newswire New!
 
Contact us
Send an email
Call us: +44 1904 520460
Request a callback
 
RSS Feeds
Keep up to date

Pharmalicensing Ltd
is a division of
UTEK Corporation
PR Newswire

News of the day

Finesse Solutions Launches TruBio 3.4 Bioreactor Control Software

10th October 2008 SANTA CLARA, California, October 10 /PRNewswire/ -- Finesse Solutions, LLC, Santa Clara, CA, a manufacturer of measurement and control solutions for life science process applications, announced the release of version 3.4 of its TruBio bioreactor control software. TruBio 3.4 software can automate bioreactors across a wide variety of applications, ranging from 1L bench top R&D glass to 1000L cGMP production single-use vessels. TruBio 3.4 software is optimized for DeltaV version 9.3 from... more

Genmab Reaches Milestone in Ofatumumab Collaboration

10th October 2008 COPENHAGEN, Denmark, October 10 /PRNewswire/ -- Genmab A/S (OMX: GEN) announced today it has reached the sixth milestone for ofatumumab (HuMax-CD20(R)) under the terms of its collaboration with GlaxoSmithKline (GSK). A milestone payment of approximately DKK 29 million (approximately USD 5.6 million) was triggered by the first patient receiving treatment in the ofatumumab Phase I study in relapsed/refractory follicular non-Hodgkin's lymphoma and chronic lymphocytic leukemia in Japan. ... more

Statement From Peter Hepburn, Cats Protection's Chief Executive, Regarding the Collapse of Kaupthing Singer and Friedlander

10th October 2008 CHELWOOD GATE, England, October 10 /PRNewswire/ -- "Cats Protection (CP) has announced that it has become a victim, alongside many other organisations, institutions, companies and private individuals, of the collapse of the bank Kaupthing Singer and Friedlander. "Cats Protection, like all charities, has to place funds with banks and it uses the banking system to maximise its income in many ways. One of these is to deposit the charity's cash reserves and gain by the interest earned. In... more
RSS feed

PR Newswire search

Search the PR Newswire by keyword. Alternatively our advanced search allows you to query by category.
Category
To choose more then one item on the list hold CTRL button while selecting. To deselect items press CTRL button and deselect.

Browse by category

More recent news

Finesse Solutions Launches Improved E-Store for Sensors and Transmitters
10th October 2008 SANTA CLARA, California, October 10 /PRNewswire/ -- Finesse Solutions, LLC, a manufacturer of measurement and control solutions for life science process applications, is pleased to...

West Suffolk Hospital NHS Trust Selects Manpower Software's MAPS Healthroster Electronic Rostering Solution
10th October 2008 LONDON, October 10 /PRNewswire/ -- Manpower Software plc, the leading provider of workforce optimisation and rostering solutions in the UK healthcare market, is pleased to announce that West Suffolk...

Merck Serono Named as a Top Employer by Science Magazine
10th October 2008 GENEVA, Switzerland, October 10 /PRNewswire/ -- Merck Serono, a division of Merck KGaA, Darmstadt, Germany, announced today that it has been named by Science magazine as a top employer in the...

Mortara Receives Frost & Sullivan Award for DICOM ECG
9th October 2008 MILWAUKEE, October 9 /PRNewswire/ -- Today Mortara Instrument announced receipt of a Frost & Sullivan Award for its incorporation of DICOM ECG into the company's diagnostic ECG modalities. In...

Media Statement From Servier: High Court of Justice Judgment
9th October 2008 SLOUGH, England, October 9 /PRNewswire/ -- Servier is disappointed by the decision of the English High Court (Mr Justice Norris) to award damages to Apotex of GBP17.5 million in the case of Les...

Abbott Opens New Research Facility and Pilot Plant in Ludwigshafen
9th October 2008 LUDWIGSHAFEN, Germany, October 9 /PRNewswire/ -- Abbott (NYSE: ABT) today announced the opening of new development laboratories and a pilot plant facility that will research...

Evalve Expands Executive Leadership Team
9th October 2008 MENLO PARK, California, October 9 /PRNewswire/ -- Evalve, Inc., the leader in the development of devices for the percutaneous repair of cardiac valves, has expanded its sales and marketing executive...

BioWa Licenses POTELLIGENT(R) Technology to CSL Limited
9th October 2008 PRINCETON, New Jersey, October 9 /PRNewswire/ -- BioWa, Inc. announced today that it has entered into a license agreement with CSL Limited, providing CSL with access to BioWa's...

First European Survey to Study the Fit and Feel of Condoms
9th October 2008 AMSTERDAM, October 9 /PRNewswire/ -- For the first time in Europe a study is being conducted among men to gain information about the fit and feel of condoms. The American Center for Sexual Health...

Diamyd(R) Study Published in Prestigious New England Journal of Medicine
9th October 2008 STOCKHOLM, October 9 /PRNewswire/ -- Diamyd Medical reports that the world's most influential medical journal, the New England Journal of Medicine, has published an article with results from the...

Nventa Provides Corporate Update and Advancement Plans for HspE7, Hsp 6/11 and Poly-ICR
8th October 2008 SAN DIEGO, October 8 /PRNewswire/ -- Nventa Biopharmaceuticals Corporation (TSX: NVN), a company developing innovative therapeutics for the treatment of viral infections and cancer, today provided an...

MatTek's EpiDerm In Vitro Tissues Headed for Validation in Europe
8th October 2008 ASHLAND, Massachusetts, October 8 /PRNewswire/ -- MatTek Corp. today announced that results of a recently completed US and European multi-laboratory "catch-up" validation study on MatTek's EpiDerm...

Genmab A/S - Company Announcement: Genmab Reports Results of Portfolio
8th October 2008 COPENHAGEN, October 8 /PRNewswire/ -- Genmab A/S (OMX: GEN) announced today that it is discontinuing development of zanolimumab (HuMax-CD4(R)). In addition, as a result of a portfolio review and...

Essex Vet Reprimanded Following Two-Year Postponement
8th October 2008 LONDON, October 8 /PRNewswire/ -- At a recently-resumed hearing, the Disciplinary Committee of the Royal College of Veterinary Surgeons has commended an Essex-based veterinary surgeon for his...

CPA Acquires Renowned German Patent Research Specialist, SVPG
8th October 2008 LONDON, October 8 /PRNewswire/ -- CPA, the world's top intellectual-property management specialist and a leading provider of outsourced legal support services, announced today that it has acquired...

First CyberKnife in Saudi Arabia to be Installed at Prestigious King Faisal Specialist Hospital and Research Center
8th October 2008 SUNNYVALE, California, October 8 /PRNewswire/ -- Accuray Incorporated (Nasdaq: ARAY), a global leader in the field of radiosurgery, announced today that the first CyberKnife(R) Robotic Radiosurgery...

Archus Orthopedics Performs First Facet Replacement Procedure With an Artificial Disc
8th October 2008 REDMOND, Washington, October 8 /PRNewswire/ -- Archus Orthopedics, Inc. today announced the first human use of its facet replacement technology to complement an artificial disc. The landmark case was...

Nventa Presents Findings on Proprietary Toll-like Receptor 3 (TLR3) Agonist, Poly-ICR, at World Vaccine Congress
8th October 2008 SAN DIEGO, October 8 /PRNewswire/ -- Nventa Biopharmaceuticals Corporation (TSX: NVN) today presented positive data from preclinical studies using its proprietary Toll-like Receptor 3 agonist, Poly...

World Sight Day - Britons at Risk of Losing Their Sight by Not Having Regular Eye Tests
8th October 2008 WALTON OAKS, England, October 9 /PRNewswire/ -- Today on World Sight Day leading experts aim to raise awareness of the eye disease glaucoma. It is estimated that there are currently up to 500,000...

Intellect Neurosciences, Inc. Grants to Top Tier Global Pharmaceutical Company an Option to License Certain Alzheimer's Patents and Patent Applications
8th October 2008 NEW YORK, October 8 /PRNewswire/ -- Intellect Neurosciences, Inc. (OTC Bulletin Board: ILNS), a biopharmaceutical company focused on development of disease-modifying therapeutic agents for the...

Stallergenes Partners With Catalent and the Medical House for Commercialization of Adrenaline Autoinjector in Europe
7th October 2008 ANTONY, France, October 7 /PRNewswire/ -- Stallergenes S.A. today announced that they have entered into an exclusive agreement with Catalent for the promotion and distribution in Europe of adrenaline...

Informex to Hold Global Sourcing Strategies Conference for the Pharmaceutical Industry
7th October 2008 PRINCETON, New Jersey, October 7 /PRNewswire/ -- Informex today announced that it will hold a Global Sourcing Summit for the Pharmaceutical Industry, November 10-11, at Princeton, New Jersey,...

CryoLife Hosts Worldwide Surgical Congress for the Ross Procedure
7th October 2008 ATLANTA, October 7 /PRNewswire/ -- CryoLife, Inc. (NYSE: CRY), a biomaterials, medical device and tissue processing company, announced today that cardiovascular surgeons from around the globe will...

Bounty Launches TV Channel for Mums
7th October 2008 LONDON, October 7 /PRNewswire/ -- Online chat forums are fast becoming the coffee morning equivalent for UK mums, and the Bounty parenting club is predicting that its new online TV channel,...

Cepheid Announces CE IVD Release of First On-Demand Test for van A/van B Genes Most Associated With Hospital-Acquired VRE Infection
7th October 2008 SUNNYVALE, California, October 7 /PRNewswire/ -- Cepheid (Nasdaq: CPHD) today announced the release of Xpert(TM) vanA/vanB as a European CE IVD Mark product under the European Directive on In...

Cognizant Formally Inaugurates Delivery Center in Hungary to Meet Global 2000 Clients' European Near-shore IT, BPO Needs
7th October 2008 TEANECK, New Jersey and BUDAPEST, Hungary, October 7 /PRNewswire/ -- Cognizant (Nasdaq: CTSH), a leading provider of global consulting, technology and business process services, announced today the...

ProGenTech Targets Clinical Diagnostics and Applied Sciences Markets with Human Genetic Signatures Deal
7th October 2008 EMERYVILLE, California, October 7 /PRNewswire/ -- ProGenTech Limited, a life sciences & diagnostics company based in Shanghai, China and Emeryville, CA has signed a licensing agreement with Human...

LENTE Clinic Announces First Patients Treated With the Advance(TM) System for Obstructive Sleep Apnea
7th October 2008 PLZEN, Czech Republic, October 7 /PRNewswire/ -- LENTE Clinic announced today that it had successfully treated its first patients with the third-generation Advance System implant for...

Bavarian Nordic Announces Positive Mature Phase II Results From Newly Acquired Prostate Cancer Vaccine
7th October 2008 KVISTG

Hospital Stays Super Bug Free for Two Years Thanks to Revolutionary British Technology
7th October 2008 MANCHESTER, England, October 7 /PRNewswire/ -- Hospital super bugs may be the biggest challenge facing the NHS but a revolutionary technology - Byotrol - developed by a pioneering British company has...

CeloNova BioSciences to Showcase the CE-Marked CATANIA(TM) Coronary Stent System Featuring NanoThin Polyzene(R)-F at TCT Debut
7th October 2008 WASHINGTON, October 7 /PRNewswire/ -- CeloNova BioSciences, Inc. today announced that it will showcase the technology behind the CATANIA(TM) Coronary Stent System featuring a NanoThin Polyzene(R)-F...

Nobel Prize to HPV Researcher Highlights Importance of Cervical Cancer Screening and Prevention
6th October 2008 VENLO, Netherlands, October 6 /PRNewswire/ -- The Nobel Prize-winning discovery of the causal link between human papillomavirus (HPV) and cervical cancer has spurred lifesaving...

Seahorse Bioscience Announces the XF96 Extracellular Flux Analyzer for Cellular Bioenergetics
6th October 2008 BILLERICA, Massachusetts, October 6 /PRNewswire/ -- Seahorse Bioscience today announced the release of the first ever analytical instrument for the kinetic measurement of mitochondrial...

Caprion Awarded US $12.9M Infectious Disease Biomarker Research Contract
6th October 2008 MONTREAL, October 6 /PRNewswire/ -- Caprion Proteomics Inc. announced today that it has been awarded a US$12.9 million contract by the National Institute of Allergy and Infectious Diseases (NIAID), a...

Grifols Breaks Ground on New IVIG Facility
6th October 2008 LOS ANGELES, October 6 /PRNewswire/ -- Today, Grifols SA (Grifols), a global healthcare company based in Barcelona, Spain, broke ground on a new 92,000 square foot, intravenous immune globulin (IVIG)...

Oncalis AG Licenses PI3K Inhibitors From ChemDiv Inc.
6th October 2008 SCHLIEREN, Switzerland, LAUSANNE, Switzerland and SAN DIEGO, October 6 /PRNewswire/ -- Oncalis AG (Oncalis), a privately-owned Swiss biotechnology company, and ChemDiv Inc. (ChemDiv), a...

Global Sourcing Strategies for the Pharmaceutical Industry 10th - 11th November, Marriott Princeton, New Jersey USA
6th October 2008 LONDON, October 6 /PRNewswire/ -- The organizers of Informex are delighted to announce their inaugural conference on Global Sourcing for the Pharmaceutical Industry, taking place November 10th-11th...

Botaneco Receives Natural Ingredient Approval From ECOCERT(R) for Hydresia(TM) G2
6th October 2008 CALGARY, Canada, October 6 /PRNewswire/ -- TSX symbol: SBS Botaneco Specialty Ingredients Inc. (Botaneco), a subsidiary of SemBioSys Genetics Inc. (SemBioSys), today announced that its second...

Alcan Packaging Acquires Pharmaceutical Flexible Packaging Facility in India
6th October 2008 PARIS, October 6 /PRNewswire/ -- Alcan Global Pharmaceutical Packaging - a division of Alcan Packaging, a business unit of Rio Tinto Alcan - has acquired the Chakan flexible packaging plant from...

Data From Multiple Clinical Trials of OrbusNeich's Genous(TM) Bio-engineered R stent(TM) to be Presented at TCT 2008
6th October 2008 HONG KONG, October 6 /PRNewswire/ -- Data from multiple clinical trials of the world's first pro-healing stent, OrbusNeich's Genous Bio-engineered R stent, will be presented next week at the...

Laborie Medical Technologies Announces Exclusive Distribution Agreement with T-DOC(R), LLC
6th October 2008 BRISTOL, England, October 6 /PRNewswire/ -- Laborie Medical Technologies is pleased to announce that an exclusive strategic agreement has been signed to carry the T-DOC(R) line of...

Credit Crunch Stopping Workers Acting on Health Issues
6th October 2008 ANDOVER, England, October 6 /PRNewswire/ -- A major new health report unveiled today reveals that the credit crunch is leading to people being less likely to take time off sick. 83% of workers...

Ageing Populations Face Crisis of Rising Blindness
4th October 2008 LONDON, October 4 /PRNewswire/ -- The world's populations are ageing rapidly, bringing greater risk of blindness and vision impairment to millions. Around the world, organisations of many kinds are...

Partnering consultation free of charge
Bioiberica
Industry news: Pharmalicensing provides comprehensive industry coverage.

© Copyright 1995-2008 Pharmalicensing Ltd, is a division of UTEK Corporation All rights reserved. Terms and Conditions | Site map | Contact us